Main Products Inc recalls Umary Acido Hialuronico
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
- Products
-
- Umary Acido Hialuronico
- Company
- Main Products Inc
- Where it was sold
-
Nationwide within the U.S
Nationwide
- Units affected
- 57, 340 bottles
- About this recall
- Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.